NRG-GU008
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer after Radical Prostatectomy (INNOVATE*)
More Information
NRG-GU009
Parallel Phase III Randomized Trials for High-Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*)
More Information
NU 17U19
Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer
More Information
AR-V7
Prevalence of AR-V7 in African American Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Novel Hormonal Agents
Taste
Taste and Prostate Cancer
LGUCR
Louisiana Genitourinary Cancer Registry (LGUCR)
Genetics
Genetic Studies of Prostate Cancer
IRONMAN
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)
More Information
Germline
Prostate Germline Consortium
Hoxton
A Phase 1 Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
More Information
PBP-301
SPLASH: Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using 177Lu-PNT2002 PSMA Therapy After Second-line Hormonal Treatment
More Information
PSMAddition
An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Clinical Trial Protocol CAAA617C12301
More Information
